Willis Investment Counsel’s Span-America Medical Systems I SPAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-86,870
Closed -$1.83M 128
2017
Q1
$1.83M Sell
86,870
-3,697
-4% -$76.3K 0.14% 106
2016
Q4
$1.65M Buy
90,567
+5,180
+6% +$95.7K 0.12% 113
2016
Q3
$1.57M Hold
85,387
0.13% 111
2016
Q2
$1.53M Buy
85,387
+600
+0.7% +$10.9K 0.13% 113
2016
Q1
$1.61M Buy
84,787
+800
+1% +$15.2K 0.14% 109
2015
Q4
$1.65M Sell
83,987
-2,610
-3% -$49K 0.15% 111
2015
Q3
$1.49M Buy
86,597
+6,732
+8% +$120K 0.15% 114
2015
Q2
$1.47M Sell
79,865
-15,754
-16% -$300K 0.14% 119
2015
Q1
$1.85M Buy
95,619
+16,710
+21% +$303K 0.17% 113
2014
Q4
$1.34M Buy
78,909
+15,441
+24% +$286K 0.13% 117
2014
Q3
$1.23M Buy
63,468
+9,420
+17% +$183K 0.13% 108
2014
Q2
$1.15M Buy
54,048
+14,353
+36% +$310K 0.11% 104
2014
Q1
$910K Buy
39,695
+24,520
+162% +$504K 0.09% 105
2013
Q4
$316 Buy
+15,175
New +$295K 0.01% 111

Other funds holding SPAN

Willis Investment Counsel's SPAN Position: Q2 2017 in Review

Willis Investment Counsel sold out of Span-America Medical Systems I (SPAN) in Q2 2017, closing a stake of 86,870 shares — an estimated $1.83M sold.

Willis Investment Counsel first reported a position in SPAN in Q4 2013 and held it in 14 quarters. The position peaked at $1.85M in Q1 2015. 2 funds tracked by Wall St. Rank hold SPAN as of Q2 2017.

  • Willis Investment Counsel reported no remaining Span-America Medical Systems I position as of Q2 2017 after selling out during the quarter.
  • Willis Investment Counsel sold 86,870 Span-America Medical Systems I shares in Q2 2017, an estimated $1.83M.
  • Willis Investment Counsel first reported a position in Span-America Medical Systems I in Q4 2013 and held it in 14 quarters.
  • Willis Investment Counsel's Span-America Medical Systems I position peaked at $1.85M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held Span-America Medical Systems I as of Q2 2017.

Based on Willis Investment Counsel's 13F filing for Q2 2017, filed 11 Aug 2017.